← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2004Last known activity
Nov 30, 2022
Acquired by TransEnterix on Sep 1, 2015
Timeline
1960s
- Jun 1, 1968
SOFAR S.p.A.— Founded
2010s
- Sep 1, 2015
TransEnterix— Acquired By
Drugs by trial phase (6 distinct, 12 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT05394207Lead sponsorN/ANov 30, 2022
- NCT04873063Lead sponsorPhase 1Oct 31, 2021
- NCT03449628Lead sponsorN/ANov 6, 2017
- NCT03793556Lead sponsorN/AMay 5, 2017
- NCT03434249Lead sponsorN/ANov 11, 2016
- NCT02988791CollaboratorN/ANov 1, 2016
- NCT02371499Lead sponsorN/ADec 1, 2014
- NCT02077777Lead sponsorPhase 2Oct 1, 2012
- NCT02077699Lead sponsorPhase 4Mar 1, 2012
- NCT00626288Lead sponsorPhase 3Dec 1, 2007
- NCT01120340Lead sponsorPhase 3Oct 1, 2005
- NCT00774007Lead sponsorPhase 2/Phase 3Sep 1, 2004
Details
- Founded
- Firenze, IT Jun 1, 1968
- Last known activity
- Nov 30, 2022